Synthesis of 1-(tert-Butyl) 4-Methyl (1R,2S,4R)-2-Methylcyclohexane-1,4-Dicarboxylate from Hagemann's tert-Butyl Ester for an Improved Synthesis of BMS-986251.

We describe an efficient synthetic route to differentially protected diester, 1-(tert-butyl) 4-methyl (1R,2S,4R)-2-methylcyclohexane-1,4-dicarboxylate (+)-1, via palladium-catalyzed methoxycarbonylation of an enol triflate derived from a Hagemann's ester derivative followed by a stereoselective Crabtree hydrogenation. Diester 1 is a novel chiral synthon useful in drug discovery and was instrumental in the generation of useful SAR during a RORt inverse agonist program. In addition, we describe a second generation synthesis of the clinical candidate BMS-986251, using diester 1 as a critical component.was instrumental in the generation of useful SAR during a RORt inverse agonist program. In addition, we describe a second generation synthesis of the clinical agent BMS-986251, using diester 1 as a critical component.